Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediate l Side chain for pacltaxel & docetaxel
  Production management QC Quality System branch factory
 
logn  

username:

 password:

 

  home
 
  Products Center
  API
Paclitaxel (Natural) USP30
Paclitaxel Semi-Synthetic USP30
Docetaxel Anhydrous
Docetaxel Trihydrate
Irinotecan Hcl Trihydrate
Palonosetron Hydrochloride
Etoposide
Fludarabine phosphate
  Intermediate
10-DAB III(10-Deacetyl Baccatin III) 99%
Baccatin III 98%
9-DHB
Sequoyitol
Podophyllotoxin
4’-Demethyl-epi- Podophyllotoxin
5-Fluoroorotic Acid Hydrate
  Side chain for pacltaxel & docetaxel
(2R,3S)-3-Phenylisoserine Hydrochloride
(2R,3S)-N-benzoyl-3-Phenylisoserine Methyl Ester
(2R,3S)-N-tert-butoxycarbonyl-3-Phenyl isoserine methyl ester
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
   
 
Your location:Home>>R & D>>Technology Strength
 
 



Our R&D center is located in Juke Biotech Park in Central Shanghai, currently equipped with 16 R&D professionals and a full set of experimental and analysis and testing equipments.

In the high-tech industry, technology innovation is the primary driven force and source strength for the company’s continuous development. The company centers on innovation, aims at the internationally advanced and domestically underdeveloped, and sustainable projects, and is deeply committed in research and development. By taking in full consideration of reasonable arrangement for short term and long term projects, it is able to complement the basic research and the applicable development, and to maintain its leading position in the R&D of Anti-cancer APIs and its relevant products.


 
 
CopyRight(C)2006,Shanghai Jinhe Bio-Technology Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE